Anemia in the elderly: How should we define it, when does it matter, and what can be done?

被引:79
作者
Steensma, David P. [1 ]
Tefferi, Ayalew [1 ]
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
关键词
D O I
10.4065/82.8.958
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anemia signifies an underlying disease and is associated with poor clinical outcomes. In elderly patients, in whom anemia has a high prevalence (> 10%), neither the hemoglobin threshold for concern nor the identity of the anemia-causing disease is easily established. This is an important shortfall, because even mild anemia can compromise patients' well-being and survival, regardless of the underlying cause. This review discusses definitions of "normal" hemoglobin levels in adults, common causes of anemia in people aged 65 years and older (eg, nutritional deficiency, renal insufficiency, inflammatory disorders, and myelodysplastic syndrome), and potential consequences of anemia in elderly patients (eg, poorer cognitive status, increased frailty, and an elevated risk of hospitalization and of complications during hospitalization). We also outline a practical initial diagnostic approach that helps determine appropriate treatment, and we weigh therapeutic options in light of new safety concerns regarding erythropoiesis-stimulating agents.
引用
收藏
页码:958 / 966
页数:9
相关论文
共 65 条
[31]   Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age [J].
Gale, RE ;
Fielding, AK ;
Harrison, CN ;
Linch, DC .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (03) :512-519
[32]  
GLASPY J, 2007, AM ASS CANC RES ANN
[33]  
GOODNOUGH LT, 1995, J LAB CLIN MED, V126, P57
[34]   Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population [J].
Green, R ;
Miller, JW .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (10) :1048-1051
[35]  
Guralnik Jack M, 2005, Hematology Am Soc Hematol Educ Program, P528
[36]   Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia [J].
Guralnik, JM ;
Eisenstaedt, RS ;
Ferrucci, L ;
Klein, HG ;
Woodman, RC .
BLOOD, 2004, 104 (08) :2263-2268
[37]   A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life [J].
Hellström-Lindberg, E ;
Gulbrandsen, N ;
Lindberg, G ;
Ahlgren, T ;
Dahl, IMS ;
Dybedal, I ;
Grimfors, G ;
Hesse-Sundin, E ;
Hjorth, M ;
Kanter-Lewensohn, L ;
Linder, O ;
Luthman, M ;
Löfvenberg, E ;
Öberg, G ;
Porwit-MacDonald, A ;
Rådlund, A ;
Samuelsson, J ;
Tangen, JM ;
Winquist, I ;
Wisloff, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) :1037-1046
[38]   Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure [J].
Horwich, TB ;
Fonarow, GC ;
Hamilton, MA ;
MacLellan, WR ;
Borenstein, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1780-1786
[39]   No positive correlation between anemia and disability in older people in Japan [J].
Ishine, M ;
Wada, T ;
Akamatsu, K ;
Cruz, MR ;
Sakagami, T ;
Kita, T ;
Matsubayashi, K ;
Okumiya, K .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) :733-734
[40]   The definition of anemia in older persons [J].
Izaks, GJ ;
Westendorp, RGJ ;
Knook, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (18) :1714-1717